ANGIOTENSIN II RECEPTOR ANTAGONISTS AND POTASSIUM

There is a risk of hyperkalaemia if angiotensin II receptor antagonists are given with potassium supplements or potassium-containing salt substitutes, particularly in those patients where other risk factors (such as advanced age, reduced renal function, and type II diabetes) are present.
Monitor potassium levels, adjusting supplementation as necessary.